Cat. No.: X24-08-YM238
Microtubule/Tubulin inhibitor, Docetaxel trihydrate, Purity ≥98%
Synonym: 148408-66-6; Taxotere trihydrate; Ocetaxel hydrate; [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-Acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate; trihydrate
- CAS Number: 148408-66-6
- Compound CID: 148123
Product Size
100 mg; 250 mg; 500 mg; 1000 mg
Properties
Description
Docetaxel trihydrate, soluble in DMSO and ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Formula
C43H59NO17
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 98 mg/mL (113.69 mM); Water: insoluble; Ethanol: 98 mg/mL (113.69 mM)
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Docetaxel trihydrate is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of various cancers such as breast cancer, lung cancer, and prostate cancer.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%
